flecainid acet prevent recurr symptomat paroxysm supraventricular tachycardia flecainid supraventricular tachycardia studi group oral acet patient document symptomat paroxysm supraventricular tachycardia psvt double-blind placebo-control crossov trial design psvt regular tachycardia beats/min evid atrioventricular dissoci studi consider patient cooper patient qualifi phase open label flecainid dose-rang phase blind fashion placebo treatment period symptomat episod psvt end treatment period efficaci paramet flecainid superior flecainid actuari freedom symptomat psvt event placebo day patient recurr symptomat psvt placebo phase patient recurr flecainid phase median time first symptomat psvt event day placebo group day flecainid group likewis interv attack median day placebo day flecainid flecainid symptomat psvt heart rate beats/min placebo patient event placebo flecainid treatment phase 